|
2025
|
Invention
|
Genetically engineered t cells with regnase-1 and/or tgfbrii disruption have improved functionali... |
|
|
Invention
|
Gene-edited natural killer cells.
The present disclosure relates to genetically modified cells (... |
|
|
G/S
|
Cells for medical or clinical use in the field of stem cell therapy for the treatment of diabetes... |
|
|
Invention
|
Methods and compositions for treating cancer.
Provided herein, in some embodiments, are methods ... |
|
|
Invention
|
Compositions and methods for gene editing by targeting transferrin.
Provided include composition... |
|
|
Invention
|
Materials and methods for treatment of hereditary haemochromatosis.
Materials and methods for tr... |
|
|
Invention
|
Messenger rna encoding cas9 for use in genome-editing systems.
The present disclosure provides o... |
|
2024
|
Invention
|
Multiplex gene editing. The present disclosure provides methods of making multiplex targeted gene... |
|
|
Invention
|
Materials and methods for controlling gene editing.
The present application provides materials a... |
|
|
Invention
|
Anti-ptk7 immune cell cancer therapy.
Provided herein, in some embodiments, are methods and comp... |
|
|
Invention
|
Ionizable lipids and ionizable lipid nanoparticles. A compound having the following structure of ... |
|
|
Invention
|
Materials and methods for treatment of usher syndrome type 2a and/or non-syndromic autosomal rece... |
|
|
Invention
|
Modulating inflammation associated with foreign body response.
Disclosed herein include methods,... |
|
|
Invention
|
Modulating expression of alas1 (5'-aminolevulinate synthase 1) gene. The present disclosure relat... |
|
|
Invention
|
Modulating expression of alas1 (5'-aminolevulinate synthase 1) gene.
The present disclosure rela... |
|
|
Invention
|
Methods and compositions for treating angiopoietin-like 3 (angptl3) related conditions.
The pres... |
|
|
G/S
|
Cells for medical or clinical use in the field of in vivo gene editing therapy for the treatment ... |
|
|
Invention
|
Gene editing for hemophilia a with improved factor viii expression.
Provided herein, in some emb... |
|
|
Invention
|
Compositions and methods for the depletion of cd117+ cells.
The invention provides compositions ... |
|
|
Invention
|
Masked chimeric antigen receptor specific to tyrosine-protein kinase like 7 (ptk7) and immune cel... |
|
|
Invention
|
Compositions and methods for gene editing.
The present application provides materials and method... |
|
|
Invention
|
Methods and assays for off-target analysis. The present disclosure provides methods, assays, nucl... |
|
|
G/S
|
Cells for medical or clinical use; pharmaceutical and biopharmaceutical agents for the treatment ... |
|
|
G/S
|
Medical and veterinary preparations and articles; pharmaceuticals; pharmaceutical and biopharmace... |
|
|
Invention
|
Materials and methods for treatment of glycogen storage disease type 1a.
The present application... |
|
2023
|
Invention
|
Materials and methods for treatment of alpha-1 antitrypsin deficiency.
The present application p... |
|
|
G/S
|
Cells for medical or clinical use; pharmaceutical and
biopharmaceutical agents for the treatment... |
|
|
G/S
|
Scientific research and development, namely, gene editing for researching and developing human ce... |
|
|
Invention
|
Compositions and methods for gene editing for hemophilia a.
Provided include materials and metho... |
|
|
Invention
|
Compositions and methods for genomic editing by insertion of donor polynucleotides.
The present ... |
|
|
Invention
|
Genetically engineered anti-cd19 car-t cells for use in treating b-cell malignancies. TRACβ2MRegn... |
|
|
Invention
|
Genetically engineered anti-cd19 car-t cells for use in treating b-cell malignancies.
Methods fo... |
|
|
Invention
|
Use of anti-cd117 antibody drug conjugate (adc). The invention relates to uses of an anti-CD117 a... |
|
|
Invention
|
Genetically engineered immune cells expressing chimeric antigen receptor targeting cd20. Genetica... |
|
|
G/S
|
Education services, namely, providing on-line
non-downloadable articles and newsletters in the f... |
|
|
Invention
|
Method for detecting mycoplasma contamination. M. arginini, M. orale, M. synoviae, M. hyorhinis, ... |
|
|
Invention
|
Genetically engineered immune cells having disrupted transporter associated with antigen processi... |
|
|
Invention
|
Viral detection assays. Methods, compositions and kits for detection of one or more of Human Parv... |
|
|
Invention
|
Chimeric antigen receptor targeting gpc-3 and immune cells expressing such for therapeutic uses. ... |
|
|
Invention
|
Compositions and methods for treating human immunodeficiency virus. in vivoCCR5CCR5 gene to treat... |
|
|
Invention
|
Methods and compositions for in vivo editing of stem cells. in vivoin vivo editing of stem cells ... |
|
|
Invention
|
Base editing proteins and uses thereof. The present disclosure provides base editing fusion prote... |
|
|
Invention
|
Cd117-targeting nanoparticles for use in drug delivery. Single domain antibody fragments binding ... |
|
|
Invention
|
Chimeric antigen receptor specific to cd117. A chimeric antigen receptor (CAR) that binds CD117 (... |
|
|
Invention
|
Lipid nanoparticles (lnps)-based ocular delivery.
Provided herein include compositions, methods ... |
|
|
Invention
|
Lipid nanoparticles (lnps)-based ocular delivery. MYOCMYOC) gene in the trabecular meshwork cells... |
|
|
Invention
|
System and method of generating test deviations. Disclosed herein include systems, devices, and m... |
|
|
Invention
|
Gene-edited natural killer cells. B2MCIITA FASCISHCD38FLI1TGFBR1TGFBR2TGFBR2 gene, an inserted po... |
|
|
Invention
|
Compositions and methods for differentiating stem cells into nk cells. The disclosure features me... |
|
|
Invention
|
Methods and compositions for treating lipoprotein-related diseases.
The present disclosure relat... |
|
|
Invention
|
Multiplex gene edited cells for cd70-directed cancer immunotherapy.
Several embodiments of the m... |
|
2022
|
G/S
|
Cells for medical or clinical use. Pharmaceutical research and development, hereunder, gene editing. |
|
|
G/S
|
Cells for medical or clinical use in the field of CAR T cell therapy for the treatment of cancer ... |
|
|
G/S
|
Cells for medical or clinical use in the field of CAR T cell therapy for the treatment of hematol... |
|
2021
|
Invention
|
Materials and methods for treatment of amyotrophic lateral sclerosis.
The present application pr... |
|
|
G/S
|
Education services, namely, providing on-line non-downloadable articles and newsletters in the fi... |
|
2019
|
G/S
|
Human cells for medical and clinical use, namely, for the treatment of human diseases in the natu... |
|
2018
|
G/S
|
Reagents for scientific and research use; kits composed of
reagents for scientific and research ... |
|
|
G/S
|
Education services, namely, providing online non-downloadable articles and newsletters in the fie... |
